RF Absorbent for the removal of IgG in human plasma/serum |
RF-ABS |
Alpha Diagnostics |
100 tests |
EUR 270 |
Human IgG antibody Laboratories manufactures the influenza antibody in the blood reagents distributed by Genprice. The Influenza Antibody In The Blood reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza Antibody. Other Influenza products are available in stock. Specificity: Influenza Category: Antibody Group: In The
Human True insulin ELISA kit |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True Insulin GENLISA ELISA |
Krishgen |
1 x 96 wells |
EUR 286 |
Human True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
In The information
Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate |
NAT41629-100 |
The Native Antigen Company |
0.1 |
EUR 512.85 |
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate |
NAT41629-500 |
The Native Antigen Company |
0.5 |
EUR 2181.53 |
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
Avian Influenza A [HPAI (H5N8)] Hemagglutinin (HA), His-Tag |
REC31991-100 |
The Native Antigen Company |
0.1 |
EUR 298.53 |
Description: Recombinant highly pathogenic avian influenza (HPAI) H5N8 hemagglutinin protein. |
Avian Influenza A [HPAI (H5N8)] Hemagglutinin (HA), His-Tag |
REC31991-500 |
The Native Antigen Company |
0.5 |
EUR 1047.4 |
Description: Recombinant highly pathogenic avian influenza (HPAI) H5N8 hemagglutinin protein. |
Avian Influenza A [HPAI (H5N8)] Neuraminidase (NA), His-Tag |
REC31993-100 |
The Native Antigen Company |
0.1 |
EUR 298.53 |
Description: Recombinant highly pathogenic avian influenza (HPAI) neuraminidase (NA) protein purified from culture supernatant of transfected cells. |
Avian Influenza A [HPAI (H5N8)] Neuraminidase (NA), His-Tag |
REC31993-500 |
The Native Antigen Company |
0.5 |
EUR 1047.4 |
Description: Recombinant highly pathogenic avian influenza (HPAI) neuraminidase (NA) protein purified from culture supernatant of transfected cells. |
Influenza B [B/Palermo/4/2013] Hemagglutinin (HA), His-Tag |
REC31890-100 |
The Native Antigen Company |
0.1 |
EUR 298.53 |
Description: Influenza B haemagglutinin protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
Influenza B [B/Palermo/4/2013] Hemagglutinin (HA), His-Tag |
REC31890-500 |
The Native Antigen Company |
0.5 |
EUR 1047.4 |
Description: Influenza B haemagglutinin protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
Influenza B [B/Beijing/184/93] Nucleoprotein (NP), His-Tag |
REC32012-100 |
The Native Antigen Company |
0.1 |
EUR 311.28 |
Description: Recombinant influenza B virus nucleoprotein. |
Influenza B [B/Beijing/184/93] Nucleoprotein (NP), His-Tag |
REC32012-500 |
The Native Antigen Company |
0.5 |
EUR 1182.63 |
Description: Recombinant influenza B virus nucleoprotein. |
Influenza B [B/Victoria/35/2013] Neuraminidase (NA), His-Tag |
REC31891-100 |
The Native Antigen Company |
0.1 |
EUR 355.94 |
Description: Influenza B virus Victoria/35/2013 neuraminidase produced in HEK293 cells and purified from culture supernatant using immobilised metal affinity chromatography and buffer exchange. |
Influenza B [B/Victoria/35/2013] Neuraminidase (NA), His-Tag |
REC31891-500 |
The Native Antigen Company |
0.5 |
EUR 1247.68 |
Description: Influenza B virus Victoria/35/2013 neuraminidase produced in HEK293 cells and purified from culture supernatant using immobilised metal affinity chromatography and buffer exchange. |
Influenza A [A/Ohio/12/2017 (H3N2)] Neuraminidase (NA), His-tag |
REC31914-100 |
The Native Antigen Company |
0.1 |
EUR 355.94 |
Description: Influenza virus A H3N2 virus neuraminidase (NA) was expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and dialysis. |
Influenza A [A/Ohio/12/2017 (H3N2)] Neuraminidase (NA), His-tag |
REC31914-500 |
The Native Antigen Company |
0.5 |
EUR 1247.68 |
Description: Influenza virus A H3N2 virus neuraminidase (NA) was expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and dialysis. |
Influenza B [B/Washington/02/2019] Hemagglutinin (HA), His-Tag |
REC31888-100 |
The Native Antigen Company |
0.1 |
EUR 298.53 |
Description: Influenza B virus Washington/02/2019 haemagglutinin, produced in HEK293 cells and purified from culture supernatant. This strain is part of the WHO vaccine recommendation for the Northern Hemisphere 2020/2021 season. |
Influenza B [B/Washington/02/2019] Hemagglutinin (HA), His-Tag |
REC31888-500 |
The Native Antigen Company |
0.5 |
EUR 1047.4 |
Description: Influenza B virus Washington/02/2019 haemagglutinin, produced in HEK293 cells and purified from culture supernatant. This strain is part of the WHO vaccine recommendation for the Northern Hemisphere 2020/2021 season. |
Influenza B [B/Washington/02/2019] Neuraminidase (NA), His-Tag |
REC31889-100 |
The Native Antigen Company |
0.1 |
EUR 355.94 |
Description: Influenza B neuraminidase protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |